Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Treprostinil Palmitil
2. Hexadecyl Treprostinil
3. Ins1009
4. 1706528-83-7
5. Treprostinil Palmitil [inn]
6. Treprostinil Palmitil [usan]
7. 8gjk87s89f
8. Unii-8gjk87s89f
9. Treprostinil Palmitil [usan:inn]
10. Ins-1009
11. Who 11087
12. Hexadecyl 2-[[(1r,2r,3as,9as)-2-hydroxy-1-[(3s)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta[g]naphthalen-5-yl]oxy]acetate
13. Chembl4650232
14. Schembl22596768
15. Glxc-26976
16. Akos040756993
17. Ms-30736
18. Hy-109163
19. Cs-0116342
20. Q27270416
21. Acetic Acid, 2-(((1r,2r,3as,9as)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3s)- 3-hydroxyoctyl)-1h-benz(f)inden-5-yl)oxy)-, Hexadecyl Ester
22. Hexadecyl 2-(((1r,2r,3as,9as)-2-hydroxy-1-((s)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1h-cyclopenta(b)naphthalen-5-yl)oxy)acetate
| Molecular Weight | 614.9 g/mol |
|---|---|
| Molecular Formula | C39H66O5 |
| XLogP3 | 12.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 26 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 76 |
| Heavy Atom Count | 44 |
| Formal Charge | 0 |
| Complexity | 727 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
25
PharmaCompass offers a list of Treprostinil Palmitil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Treprostinil Palmitil manufacturer or Treprostinil Palmitil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Treprostinil Palmitil manufacturer or Treprostinil Palmitil supplier.
A Treprostinil hexadecyl ester manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Treprostinil hexadecyl ester, including repackagers and relabelers. The FDA regulates Treprostinil hexadecyl ester manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Treprostinil hexadecyl ester API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Treprostinil hexadecyl ester supplier is an individual or a company that provides Treprostinil hexadecyl ester active pharmaceutical ingredient (API) or Treprostinil hexadecyl ester finished formulations upon request. The Treprostinil hexadecyl ester suppliers may include Treprostinil hexadecyl ester API manufacturers, exporters, distributors and traders.
click here to find a list of Treprostinil hexadecyl ester suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Treprostinil hexadecyl ester as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Treprostinil hexadecyl ester API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Treprostinil hexadecyl ester as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Treprostinil hexadecyl ester and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Treprostinil hexadecyl ester NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Treprostinil hexadecyl ester suppliers with NDC on PharmaCompass.
Treprostinil hexadecyl ester Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Treprostinil hexadecyl ester GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Treprostinil hexadecyl ester GMP manufacturer or Treprostinil hexadecyl ester GMP API supplier for your needs.
A Treprostinil hexadecyl ester CoA (Certificate of Analysis) is a formal document that attests to Treprostinil hexadecyl ester's compliance with Treprostinil hexadecyl ester specifications and serves as a tool for batch-level quality control.
Treprostinil hexadecyl ester CoA mostly includes findings from lab analyses of a specific batch. For each Treprostinil hexadecyl ester CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Treprostinil hexadecyl ester may be tested according to a variety of international standards, such as European Pharmacopoeia (Treprostinil hexadecyl ester EP), Treprostinil hexadecyl ester JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Treprostinil hexadecyl ester USP).